Johnson&Johnson

US Court Rules against J&J Bankruptcy Scheme

A US federal appeals court panel has unanimously dismissed an attempt by Johnson & Johnson to use a controversial procedure that could resolve claims from lawsuits claiming the healthcare group’s talc-based baby powder caused their cancer.

Topics • Strategy

M&A in Chemicals & Pharmaceuticals

News

Merck Sees Fast Ruling in Johnson and Johnson's Remicade Arbitration

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

KPMG